• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Lilly reneges on remainder of Rigel RIPK1 deal

    FIERCE BIOTECH

    Rigel Unveils 2025 Financial Results And Business Update

    PR NEWSWIRE

    Rigel Provides Business Update And 2026 Outlook

    PR NEWSWIRE

    Rigel To Present At 44th J.P. Morgan Healthcare Conference

    PR NEWSWIRE

    Rigel Updates Ph1b Data for R289 in Lower-Risk MDS at ASH

    PR NEWSWIRE

    Rigel to Present at Piper Sandler Healthcare Conference

    PR NEWSWIRE

    Rigel Publishes 5-Year Rezlidhia Data in R/R mIDH1 AML

    PR NEWSWIRE

    Rigel To Present At Jefferies Global Healthcare Conference

    PR NEWSWIRE

    Lilly Pulls Out Of CNS Portion Of $960M Collab With Rigel

    FIERCE BIOTECH

    Rigel Reports Q3 2025 Financials & Business Update

    PR NEWSWIRE

    Rigel Presents Five Studies at ASH Annual Meeting

    PR NEWSWIRE

    Rigel Enrolls 1st Patient Enrolled In Dose Expansion Ph 1 Of R289

    PR NEWSWIRE

    Rigel to Participate in Upcoming September Investor Conferences

    PR NEWSWIRE

    Rigel Reports Q2 2025 Financials, Updates on Business

    PR NEWSWIRE

    Rigel to Present at the Jefferies Global Healthcare Conference

    PR NEWSWIRE

    Rigel to Present Posters at 2025 ASCO and EHA2025 Congress

    PR NEWSWIRE

    Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors

    PR NEWSWIRE

    Rigel to Present at 43rd Annual J.P. Morgan Healthcare Conference

    PR NEWSWIRE

    Rigel Reports Initial Data from Phase 1b R289 in LR-MDS Study

    PR NEWSWIRE

    Rigel Announces Fast Track for R289 in Lower-Risk MDS

    PR NEWSWIRE

    Rigel Reports Q3 2024 Financials & Business Update

    PR NEWSWIRE

    Rigel Announces Inducement Grants Under NASDAQ Rule

    PR NEWSWIRE

    Rigel to Present at the 2024 Cantor Global Healthcare Conference

    PR NEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.